Clinical Trial

1726-nm Diode Laser for Lip Fordyce Spots

Recruiting
View on ClinicalTrials.gov →
Summary
Fordyce spots are benign ectopic sebaceous glands commonly affecting the lips and vermilion border, often causing cosmetic concern. This prospective pilot study evaluates the efficacy and safety of a 1726-nm sebaceous-targeting diode laser (Accure®) for the cosmetic treatment of Fordyce spots of the lips. Participants will receive 2-3 laser sessions and will be followed for 6-12 months to assess clinical improvement, patient satisfaction, and safety outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-21.
Trial Details
NCT Number NCT07300917
Lead Sponsor Venus Research Center
Conditions Fordyce Spots
Enrollment 20 participants
Start Date 2025-11-01
Primary Completion 2026-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-26